Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients.
AUTOR(ES)
Boivin, G
RESUMO
The cytomegalovirus (CMV) DNA load in leukocytes was measured in 26 immunocompromised patients with CMV disease before and after 10 days of intravenous ganciclovir therapy. Before therapy, the circulating DNA burden of bone marrow transplant recipients was significantly lower than that of other transplant or AIDS patients. Ganciclovir induction therapy significantly decreased the viral DNA load in the leukocyte populations of most patients.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163812Documentos Relacionados
- Intravitreal therapy with ganciclovir for posterior pole cytomegalovirus retinitis in AIDS patients.
- Nonpulmonary manifestations of cytomegalovirus infection in immunocompromised patients.
- Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes.
- Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.
- Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients.
